Pictet Asset Management (UK)’s AMAG Pharmaceuticals AMAG Stock Holding History

Pictet Asset Management (UK)’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-71,800	Closed	-$4.59M	–	903
2015 Q2	$4.59M	Sell	71,800 -15,000	-17%	-$944K	0.02%	613
2015 Q1	$4.42M	Sell	86,800 -44,400	-34%	-$2.12M	0.02%	610
2014 Q4	$5.59M	Buy	131,200 +6,500	+5%	+$235K	0.03%	547
2014 Q3	$3.98M	Buy	+124,700	New	+$2.66M	0.02%	589
2013 Q4	–	Sell	-185,600	Closed	-$3.99M	–	886
2013 Q3	$3.99M	Sell	185,600 -83,600	-31%	-$1.98M	0.02%	572
2013 Q2	$5.99M	Buy	+269,200	New	+$5.93M	0.03%	439

Other funds holding AMAG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management (UK)'s AMAG Position: Q3 2015 in Review

Pictet Asset Management (UK) sold out of AMAG Pharmaceuticals (AMAG) in Q3 2015, closing a stake of 71,800 shares — an estimated $4.59M sold.

Pictet Asset Management (UK) first reported a position in AMAG in Q2 2013 and held it in 6 quarters. The position peaked at $5.99M in Q2 2013. 210 funds tracked by Wall St. Rank hold AMAG as of Q3 2015.

Pictet Asset Management (UK) reported no remaining AMAG Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Pictet Asset Management (UK) sold 71,800 AMAG Pharmaceuticals shares in Q3 2015, an estimated $4.59M.
Pictet Asset Management (UK) first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 6 quarters.
Pictet Asset Management (UK)'s AMAG Pharmaceuticals position peaked at $5.99M in Q2 2013.
210 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2015.

Based on Pictet Asset Management (UK)'s 13F filing for Q3 2015, filed 12 Nov 2015.